<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04028694000188</udiDi>
    <basicUdiDi>4028694VISGEL2Z</basicUdiDi>
    <tradeName>04028694000188</tradeName>
    <deviceName>VISMED® GEL</deviceName>
    <manufacturerName>TRB Chemedica AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006919</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04028694000188</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:08:45.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>04028694000133</udiDi>
    <basicUdiDi>4028694VISMED3F</basicUdiDi>
    <tradeName>04028694000133</tradeName>
    <deviceName>VISMED®</deviceName>
    <manufacturerName>TRB Chemedica AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006919</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04028694000133</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:08:45.412Z</lastUpdated>
  </row>
  <row>
    <udiDi>04028694000027</udiDi>
    <basicUdiDi>4028694VISLUBE9X</basicUdiDi>
    <tradeName>04028694000027</tradeName>
    <deviceName>VISLUBE®</deviceName>
    <manufacturerName>TRB Chemedica AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006919</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04028694000027</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:08:43.245Z</lastUpdated>
  </row>
  <row>
    <udiDi>04893629901379</udiDi>
    <basicUdiDi>038065GMN000009GV</basicUdiDi>
    <tradeName>ProVisc</tradeName>
    <deviceName>Provisc Ophthalmic Viscosurgical Device</deviceName>
    <manufacturerName>Alcon Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000016248</manufacturerSrn>
    <authorisedRepresentativeName>Alcon Laboratories Belgium</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000014721</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>0005690059</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-30T15:30:14.676Z</lastUpdated>
  </row>
  <row>
    <udiDi>04049336249345</udiDi>
    <basicUdiDi>B-04049336249345</basicUdiDi>
    <tradeName>Z-CELCOAT single pack</tradeName>
    <deviceName>Z-CELCOAT single pack</deviceName>
    <manufacturerName>Carl Zeiss Meditec AG</manufacturerName>
    <manufacturerSrn>DE-MF-000007732</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-29T20:32:12.005Z</lastUpdated>
  </row>
  <row>
    <udiDi>05391533198957</udiDi>
    <basicUdiDi>539153319OHPMCF7</basicUdiDi>
    <tradeName>05391533198957</tradeName>
    <deviceName>Hydroxypropyl  Methyl Cellulose  Ophthalmic Solutions</deviceName>
    <manufacturerName>Biotech Europe Meditech Inc Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000004695</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>OPTIFLEX HPMC 2 ml PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-27T22:09:49.836Z</lastUpdated>
  </row>
  <row>
    <udiDi>05391533198926</udiDi>
    <basicUdiDi>539153319OVDMC</basicUdiDi>
    <tradeName>05391533198926</tradeName>
    <deviceName>Sodium Hyaluronate Ophthalmic Solutions</deviceName>
    <manufacturerName>Biotech Europe Meditech Inc Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000004695</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>OPTIFLEX HA 10mg/ml, 1 ml PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-27T22:09:47.429Z</lastUpdated>
  </row>
  <row>
    <udiDi>05391533198933</udiDi>
    <basicUdiDi>539153319OVDMC</basicUdiDi>
    <tradeName>05391533198933</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Biotech Europe Meditech Inc Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000004695</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Optiflex HA 14mg/ml, 1ml PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-27T19:59:50.104Z</lastUpdated>
  </row>
  <row>
    <udiDi>05391533198940</udiDi>
    <basicUdiDi>539153319OVDMC</basicUdiDi>
    <tradeName>05391533198940</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Biotech Europe Meditech Inc Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000004695</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Optiflex HA 24mg/ml, 1ml PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-27T19:59:49.392Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710217</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>FATS</tradeName>
    <deviceName>Sterile Viscoelastic OVD (Ophthalmic Viscosurgical Device)</deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTSA1010</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-23T19:52:11.930Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001214</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>HYLO NIGHT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2525</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.895Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001368</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2493</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.859Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001559</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>VitA POS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2646</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.620Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001597</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>HYLO NIGHT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0074</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.547Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001689</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>HYLO NIGHT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0075</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.522Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001795</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2643</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.391Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001801</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>VitA POS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.0647</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.372Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001856</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>VitA Nuit</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.0825</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.321Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001900</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>VitA POS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>38.1762</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.208Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002006</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>HYLO NIGHT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.0006</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.133Z</lastUpdated>
  </row>
</eudamedExport>